PALO ALTO, Calif., Aug. 19, 2019 /PRNewswire/ -- Varian (NYSE:
VAR) today announced that its executive management team will be
hosting an Investor Day on Friday, November
15, 2019 at The Plaza Hotel, Fifth Avenue at Central Park
South, New York, NY 10019, from
8:00am to 1:00pm ET.
Varian will outline its growth initiatives in radiation
oncology, interventional oncology, and more broadly across cancer
care driven by its 'Intelligent Cancer Care' approach, the next
wave of progress in oncology that harnesses advanced technologies
like artificial intelligence, machine learning, and data analytics
to ensure coordination and connectivity at every point of
care. 'Intelligent Cancer Care' puts the patient and provider
at the center of our thinking to help realize our vision of a world
without fear of cancer.
Information about the webcast of the company's presentation will
be available through a link on the company website at
www.varian.com/investors.
To attend Varian's investor day meeting, please RSVP to
Katie Glenn at
katie.glenn@varian.com by October 25,
2019.
For automatic e-mail alerts regarding Varian news and events,
investors can subscribe on the company website:
http://investors.varian.com/emailalerts.
About Varian
At Varian, we envision a world without
fear of cancer. For more than 70 years, we have developed,
built and delivered innovative cancer care technologies and
solutions for our clinical partners around the globe to help them
treat millions of patients each year. With an Intelligent
Cancer Care approach, we are harnessing advanced technologies like
artificial intelligence, machine learning and data analytics to
enhance cancer treatment and expand access to care. Our 9,200
employees across 70 countries keep the patient and our clinical
partners at the center of our thinking as we power new victories in
cancer care. Because, for cancer patients everywhere, their
fight is our fight. For more information, visit
http://www.varian.com and follow @VarianMedSys on Twitter.
Forward-Looking Statements
Except for historical
information, this news release contains forward-looking statements
within the meaning of the Private Securities Litigation Reform Act
of 1995. Statements concerning the expected impact of proposed
tariffs or other financial results; and any statements using the
terms "could," "believe," "expect," "promising," "outlook,"
"should," "well-positioned," "will" or similar statements are
forward-looking statements that involve risks and uncertainties
that could cause the company's actual results to differ materially
from those anticipated. Such risks and uncertainties include the
final terms of any new tariffs and whether any reciprocal tariffs
are imposed, our ability to achieve expected synergies from
acquisitions; risks associated with integrating recent
acquisitions; global economic conditions and changes to trends for
cancer treatment regionally; currency exchange rates and tax rates;
the impact of the Tax Cuts and Jobs Act; the impact of the
Affordable Health Care for America Act (including excise taxes on
medical devices) and any further healthcare reforms (including
changes to Medicare and Medicaid), and/or changes in third-party
reimbursement levels; recent and potential future tariffs or a
global trade war; demand for and delays in delivery of the
company's products; the company's ability to develop, commercialize
and deploy new products; the company's ability to meet Food and
Drug Administration (FDA) and other regulatory requirements,
regulations or procedures; changes in regulatory environments;
risks associated with the company providing financing for the
construction and start-up operations of particle therapy centers,
challenges associated with commercializing the company's proton
solutions business; challenges to public tender awards and the loss
of such awards or other orders; the effect of adverse publicity;
the company's reliance on sole or limited-source suppliers; the
company's ability to maintain or increase margins; the impact of
competitive products and pricing; the potential loss of key
distributors or key personnel; challenges related to entering into
new business lines; and the other risks listed from time to time in
the company's filings with the Securities and Exchange Commission,
which by this reference are incorporated herein. The company
assumes no obligation to update or revise the forward-looking
statements in this release because of new information, future
events, or otherwise.
Press Contact
Mark
Plungy
Director, Public Relations
+1 (650) 424-5630
mark.plungy@varian.com
Investor Relations Contact
J. Michael Bruff
Senior Vice President, Investor Relations
+1 (650) 424-5163
investors@varian.com
View original
content:http://www.prnewswire.com/news-releases/varian-to-hold-investor-day-in-new-york-city-300903347.html
SOURCE Varian